{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T03:49:02Z","timestamp":1775879342276,"version":"3.50.1"},"reference-count":27,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2023,12,31]]},"DOI":"10.1080\/13696998.2022.2152600","type":"journal-article","created":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T07:59:07Z","timestamp":1669708747000},"page":"34-42","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":15,"title":["Health care resource utilization patterns among patients with Parkinson\u2019s disease psychosis: analysis of Medicare beneficiaries treated with pimavanserin or other-atypical antipsychotics"],"prefix":"10.1080","volume":"26","author":[{"given":"Krithika","family":"Rajagopalan","sequence":"first","affiliation":[{"name":"Anlitiks Inc, Dover, MA, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazia","family":"Rashid","sequence":"additional","affiliation":[{"name":"Acadia Pharmaceuticals, San Diego, CA, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shikhar","family":"Kumar","sequence":"additional","affiliation":[{"name":"Former employee of Anlitiks Inc, Dover, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilesh","family":"Doshi","sequence":"additional","affiliation":[{"name":"Acadia Pharmaceuticals, San Diego, CA, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,12,13]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2014.10.033"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2016.200"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2000.tb06891.x"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.13702"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-018-0058-0"},{"issue":"2","key":"e_1_3_5_7_1","first-page":"64","article-title":"Role of serotonin in the action of atypical antipsychotic drugs","volume":"3","author":"Meltzer HY.","year":"1995","unstructured":"Meltzer HY. Role of serotonin in the action of atypical antipsychotic drugs. Clin Neurosci. 1995;3(2):64\u201375.","journal-title":"Clin Neurosci"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2009.02900.x"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000000342"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62106-6"},{"issue":"10","key":"e_1_3_5_11_1","first-page":"S199","article-title":"Parkinson\u2019s disease psychosis: symptoms, management, and economic burden","volume":"21","author":"Hermanowicz N","year":"2015","unstructured":"Hermanowicz N, Edwards K. Parkinson\u2019s disease psychosis: symptoms, management, and economic burden. Am J Manag Care. 2015;21(10 Suppl):S199\u2013S206.","journal-title":"Am J Manag Care"},{"issue":"5","key":"e_1_3_5_12_1","first-page":"S83","article-title":"Parkinson\u2019s disease and Parkinson\u2019s disease psychosis: a perspective on the challenges, treatments, and economic burden","volume":"23","author":"Fredericks D","year":"2017","unstructured":"Fredericks D, Norton JC, Atchison C, et\u00a0al. Parkinson\u2019s disease and Parkinson\u2019s disease psychosis: a perspective on the challenges, treatments, and economic burden. Am J Manag Care. 2017;23(5 Suppl):S83\u2013s92.","journal-title":"Am J Manag Care"},{"key":"e_1_3_5_13_1","article-title":"Risk of hospital admission in patients with Parkinson\u2019s disease associated psychosis (1991-2010) [abstract]","author":"Stang C","year":"2020","unstructured":"Stang C, Hajeb M, Camerucci E, et\u00a0al. Risk of hospital admission in patients with Parkinson\u2019s disease associated psychosis (1991-2010) [abstract]. Mov Disord. 2020;35(suppl 1). Available from: https:\/\/www.mdsabstracts.org\/abstract\/risk-of-hospital-admission-in-patients-with-parkinsons-disease-associated-psychosis-1991-2010\/","journal-title":"Mov Disord"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2019.10.018"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2015.03.024"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-010-5786-y"},{"key":"e_1_3_5_17_1","volume-title":"Nuplazid\u00ae (pimavanserin) prescribing information","author":"Acadia Pharmaceuticals.","year":"2018","unstructured":"Acadia Pharmaceuticals. Nuplazid\u00ae (pimavanserin) prescribing information. San Diego, (CA): Acadia Pharmaceuticals Inc. ; 2018."},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-013-0238-x"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200825080-00004"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-013-0281-2"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27602"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.151.2.237"},{"key":"e_1_3_5_23_1","article-title":"Mental health and substance abuse issues among people with HIV lessons from HCSUS","author":"Beckett MK","year":"2007","unstructured":"Beckett MK, Collins RL, Burnam MA, et\u00a0al. Mental health and substance abuse issues among people with HIV lessons from HCSUS. RAND Corporation, RB-9300, 2007.","journal-title":"RAND Corporation, RB-9300"},{"key":"e_1_3_5_24_1","unstructured":"Substance Abuse and Mental Health Services Administration. Co-occurring disorders and other health conditions [published 2022 Apr 21; updated 2022 Apr 21; accessed 2022 July 29]. Available from: https:\/\/www.samhsa.gov\/medication-assisted-treatment\/medications-counseling-related-conditions\/co-occurring-disorders"},{"issue":"4","key":"e_1_3_5_25_1","first-page":"338","article-title":"Integrating care for people with co-occurring alcohol and other drug, medical, and mental health conditions","volume":"33","author":"Sterling S","year":"2011","unstructured":"Sterling S, Chi F, Hinman A. Integrating care for people with co-occurring alcohol and other drug, medical, and mental health conditions. Alcohol Res Health. 2011;33(4):338\u2013349.","journal-title":"Alcohol Res Health"},{"key":"e_1_3_5_26_1","volume-title":"Montreal: SAS Institute","author":"Parsons LS.","year":"2004","unstructured":"Parsons LS. Performing a 1: n case-control match on propensity score [computer program]. Montreal: SAS Institute; 2004. Available from: https:\/\/support.sas.com\/resources\/papers\/proceedings\/proceedings\/sugi29\/165-29.pdf"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.publhealth.20.1.125"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.9740\/mhc.2017.11.262"}],"updated-by":[{"DOI":"10.1080\/13696998.2024.2320008","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000}}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2022.2152600","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T11:50:31Z","timestamp":1708429831000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2022.2152600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,13]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,12,31]]}},"alternative-id":["10.1080\/13696998.2022.2152600"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2022.2152600","relation":{"correction":[{"id-type":"doi","id":"10.1080\/13696998.2024.2320008","asserted-by":"object"}]},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,13]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-10-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-24","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}